Ads
related to: afp blood test tumor marker levels ovarian cancer prognosis- Treatment Effectiveness
Read About How Treatment Works And
Its Benefits And Risks In Patients.
- About PARP Inhibitors
Learn About How Treatment Works.
Learn About Maintenance Therapy.
- First-Line Maintenance
Learn About First-Line Treatment.
Download Helpful Resources & Info.
- Safety And Side Effects
Read Important Safety Information.
Learn More About A Treatment.
- Talk To Your Doctor
Get Resources To Help Stay Informed
To Make Your Conversation Easier.
- Tablet Dosing Info
Learn About Tablet Dosing For
An Ovarian Cancer Treatment.
- Treatment Effectiveness
Search results
Results From The WOW.Com Content Network
Elevated alpha-fetoprotein refers to a state where alpha-fetoprotein levels are outside of the reference range. There are two categories of AFP tests: tests performed on serum (blood plasma), and tests performed on amniotic fluid. Tests performed on serum are further categorized by the reason for performing the test: maternal serum, adult tumor ...
Other tumor markers for ovarian cancer include CA19-9, CA72-4, CA15-3, immunosuppressive acidic protein, haptoglobin-alpha, OVX1, mesothelin, lysophosphatidic acid, osteopontin, and fibroblast growth factor 23. [31] Use of blood test panels may help in diagnosis.
A panel of epigenetic methylation marker has been explored for prognosis of ovarian cancer, and it is reported that the panel exhibited high specificity and sensitivity (both above 70%) as a screen marker. [5] Epigenetic markers have also shown promising potential as prognostic markers for bladder cancer. [6]
Very high AFP levels may be subject to hooking (see Tumor marker), which results in the level being reported significantly lower than the actual concentration. [29] This is important for analysis of a series of AFP tumor marker tests, e.g. in the context of post-treatment early surveillance of cancer survivors, where the rate of decrease of AFP ...
Genetic, [1] epigenetic, [2] proteomic, [3] glycomic, [4] and imaging biomarkers can be used for cancer diagnosis, prognosis, and epidemiology. Ideally, such biomarkers can be assayed in non-invasively collected biofluids like blood or serum. [5] Cancer is a disease that affects society at a world-wide level.
OGCTs are commonly found during pregnancy when an adnexal mass is found during a pelvic examination, ultrasound scans show a solid mass in ovary or blood serum test shows elevated alpha-fetoprotein levels. [1] They are unlikely to have metastasized and therefore the standard tumor management is surgical resection, coupled with chemotherapy. [2]
Ad
related to: afp blood test tumor marker levels ovarian cancer prognosis